Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Ahlman

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Blood Advances|November 8, 2023
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trialJennifer N Brudno, Danielle A Natrakul, Jeremiah Karrs, et al.
Arthritis Care & Research|December 7, 2023
Development of the Takayasu Arteritis Integrated Disease Activity IndexChiara Marvisi, Ertugrul Cagri Bolek, Mark A Ahlman, et al.
Haematologica|May 12, 2018
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision makingChristopher Melani, Ranjana Advani, Mark Roschewski, et al.
Abdominal Radiology (New York)|March 10, 2021
<sup>18</sup>Fluorodeoxyglucose-positron emission tomography/computed tomography for differentiation of renal tumors in hereditary kidney cancer syndromesMoozhan Nikpanah, Anna K Paschall, Mark A Ahlman, et al.
Blood Advances|December 17, 2021
Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapyElizabeth M Holland, Bonnie Yates, Alex Ling, et al.
Clinical Imaging|December 21, 2023
Skeletal involvement in Erdheim-Chester disease: Multimodality imaging features and association with the BRAF<sup>V600E</sup> mutationMoozhan Nikpanah, Fatemeh Dehghani Firouzabadi, Faraz Farhadi, et al.
Atherosclerosis|August 27, 2019
Serum active 1,25(OH)<sub>2</sub>D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolic and cardiovascular disease risk in psoriasisMartin P Playford, Amit K Dey, Claudia Zierold, et al.
Journal of the American College of Cardiology|September 9, 2017
Unraveling Vascular Inflammation: From Immunology to ImagingHeather L Teague, Mark A Ahlman, Abass Alavi, et al.
The New England Journal of Medicine|July 6, 2017
PD-1 Blockade in Mediastinal Gray-Zone LymphomaChristopher Melani, Ajay Major, Jeffrey Schowinsky, et al.
Atherosclerosis|July 5, 2016
Self-reported depression in psoriasis is associated with subclinical vascular diseasesTsion M Aberra, Aditya A Joshi, Joseph B Lerman, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Blood Advances|November 8, 2023
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trialJennifer N Brudno, Danielle A Natrakul, Jeremiah Karrs, et al.
Arthritis Care & Research|December 7, 2023
Development of the Takayasu Arteritis Integrated Disease Activity IndexChiara Marvisi, Ertugrul Cagri Bolek, Mark A Ahlman, et al.
Haematologica|May 12, 2018
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision makingChristopher Melani, Ranjana Advani, Mark Roschewski, et al.
Abdominal Radiology (New York)|March 10, 2021
<sup>18</sup>Fluorodeoxyglucose-positron emission tomography/computed tomography for differentiation of renal tumors in hereditary kidney cancer syndromesMoozhan Nikpanah, Anna K Paschall, Mark A Ahlman, et al.
Blood Advances|December 17, 2021
Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapyElizabeth M Holland, Bonnie Yates, Alex Ling, et al.
Clinical Imaging|December 21, 2023
Skeletal involvement in Erdheim-Chester disease: Multimodality imaging features and association with the BRAF<sup>V600E</sup> mutationMoozhan Nikpanah, Fatemeh Dehghani Firouzabadi, Faraz Farhadi, et al.
Atherosclerosis|August 27, 2019
Serum active 1,25(OH)<sub>2</sub>D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolic and cardiovascular disease risk in psoriasisMartin P Playford, Amit K Dey, Claudia Zierold, et al.
Journal of the American College of Cardiology|September 9, 2017
Unraveling Vascular Inflammation: From Immunology to ImagingHeather L Teague, Mark A Ahlman, Abass Alavi, et al.
The New England Journal of Medicine|July 6, 2017
PD-1 Blockade in Mediastinal Gray-Zone LymphomaChristopher Melani, Ajay Major, Jeffrey Schowinsky, et al.
Atherosclerosis|July 5, 2016
Self-reported depression in psoriasis is associated with subclinical vascular diseasesTsion M Aberra, Aditya A Joshi, Joseph B Lerman, et al.
Pageof 8